ORG Wealth Partners LLC Decreases Stake in DaVita Inc. (NYSE:DVA)

ORG Wealth Partners LLC lessened its position in shares of DaVita Inc. (NYSE:DVA) by 15.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 503 shares of the company’s stock after selling 89 shares during the quarter. ORG Wealth Partners LLC’s holdings in DaVita were worth $75,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. TD Asset Management Inc increased its position in DaVita by 2.0% in the second quarter. TD Asset Management Inc now owns 14,046 shares of the company’s stock worth $1,946,000 after purchasing an additional 278 shares during the last quarter. Acadian Asset Management LLC bought a new stake in shares of DaVita in the 2nd quarter worth about $212,000. Caprock Group LLC purchased a new stake in shares of DaVita during the 2nd quarter valued at about $276,000. Daiwa Securities Group Inc. lifted its holdings in shares of DaVita by 9.5% in the 2nd quarter. Daiwa Securities Group Inc. now owns 5,839 shares of the company’s stock valued at $809,000 after acquiring an additional 507 shares during the last quarter. Finally, Forsta AP Fonden grew its position in DaVita by 44.5% in the second quarter. Forsta AP Fonden now owns 34,100 shares of the company’s stock worth $4,725,000 after acquiring an additional 10,500 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Truist Financial raised their price objective on DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Barclays raised their price target on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, DaVita currently has an average rating of “Hold” and an average price target of $161.80.

DaVita Price Performance

Shares of DVA stock opened at $153.20 on Friday. The stock has a 50 day moving average price of $155.41 and a 200 day moving average price of $151.89. DaVita Inc. has a 52-week low of $103.40 and a 52-week high of $169.51. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. The firm has a market capitalization of $12.56 billion, a P/E ratio of 16.53, a P/E/G ratio of 0.86 and a beta of 0.92.

DaVita (NYSE:DVA) last released its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.17). The business had revenue of $3.26 billion for the quarter, compared to the consensus estimate of $3.25 billion. DaVita had a return on equity of 88.18% and a net margin of 6.53%. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the business posted $2.85 earnings per share. As a group, sell-side analysts predict that DaVita Inc. will post 9.71 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.